Galya Blachman
General Counsel bei 501 ACQU
Ursprung des Netzwerks ersten Grades von Galya Blachman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Cambridge
224
| College/University | Other Consumer Services | 224 |
University of Oxford
161
| College/University | Other Consumer Services | 161 |
University of Cape Town
108
| College/University | Other Consumer Services | 108 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US.
40
| Private Company | Investment Managers | 40 |
| Public Company | Biotechnology | 11 | |
BPP Law School
10
| College/University | Other Consumer Services | 10 |
7
| Private Company | Financial Conglomerates | 7 |
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA.
3
| Extinct | Biotechnology | 3 |
Biotech Connection-Bay Area, Inc.
2
| Private Company | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Galya Blachman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Consultant / Advisor Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
The Assay Depot, Inc.
 The Assay Depot, Inc. Miscellaneous Commercial ServicesCommercial Services The Assay Depot, Inc. operates as a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services. It serves large and small pharmaceutical companies, government institutes, biotechnology companies, academic researchers and citizen scientists. The company was founded by Christopher L. Petersen, Andrew B. Martin, and Kevin D. Lustig in 2007 and is headquartered in Solana Beach, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Purigen Biosystems, Inc.
 Purigen Biosystems, Inc. BiotechnologyHealth Technology Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree Director/Board Member | |
| Imperial College London | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Los Angeles | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| The University of Edinburgh | College/University | Doctorate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | President Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Director/Board Member | |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Precision NanoSystems, Inc.
 Precision NanoSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Precision NanoSystems, Inc. manufactures equipment related to testing electricity and electrical Signals. It develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. The company was founded by Robert James Taylor and Euan Ramsay in 2010 and is headquartered in Vancouver, Canada. | Electronic Equipment/Instruments | Director/Board Member Chairman Director/Board Member Chairman | |
| EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member General Counsel | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| 5AM Partners V LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
Magnetic Insight, Inc.
 Magnetic Insight, Inc. BiotechnologyHealth Technology Magnetic Insight, Inc. provides magnetic particle imaging technology. The firm specializes in preclinical, medical, and diagnostic imaging. The company was founded by Anna Christensen and Patrick Goodwill and is headquartered in Alameda, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| VOR BIOPHARMA INC. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
| AKOUOS | Biotechnology | Director/Board Member Chairman | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member | |
Modis Therapeutics, Inc.
 Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ENTRADA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
| 5AM Opportunities I GP LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Founder Founder Director/Board Member | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Founder Chairman | |
| 5am Partners Vi LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| RALLYBIO CORPORATION | Biotechnology | Founder Director/Board Member Director/Board Member | |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member Director/Board Member | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Investor |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 5 |
| Dänemark | 2 |
| Kanada | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 4 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 337 |
| Corporate Officer/Principal | 149 |
| Independent Dir/Board Member | 88 |
| Undergraduate Degree | 87 |
| Private Equity Investor | 68 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Andrew Schwab | 45 |
| Richard Heyman | 33 |
| Scott Rocklage | 32 |
| Kush Parmar | 32 |
| John Diekman | 29 |
| Rishi Gupta | 29 |
| Martin MacKay | 28 |
| Jake Bauer | 24 |
| Andrew Phillips | 23 |
| Brian Daniels | 20 |
| Alexander Semenovich Vinokurov | 19 |
| Arthur Tzianabos | 15 |
| David Allison | 15 |
| Elliott Levy | 14 |
| Peter Kim | 14 |
- Börse
- Insiders
- Galya Blachman
- Unternehmensverbindungen
